NASDAQ:IMCR Immunocore Q1 2025 Earnings Results & Report $27.81 -1.07 (-3.70%) Closing price 04:00 PM EasternExtended Trading$27.79 -0.02 (-0.07%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Immunocore beat analyst expectations on both earnings and revenue in its Q1 2025 results, released May 7, 2025. The company reported EPS of $0.10 versus the -$0.35 consensus estimate, while revenue of $125.13 million topped the $108.82 million estimate by $16.32 million. Revenue increased 33.6% year over year. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2025Report DateMay 7, 2025TimeBefore Market OpensConference Call7:00 AM ET Immunocore EPS ResultsActual EPS$0.10Consensus EPS -$0.35Beat/MissBeat by +$0.45One Year Ago EPS-$0.49EPS Beat Rate5 of last 8 quartersImmunocore Revenue ResultsActual Revenue$125.13 millionExpected Revenue$108.82 millionBeat/MissBeat by +$16.32 millionYoY Revenue Growth+33.60%Conference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Immunocore Q1 2025 Earnings FAQ Did Immunocore beat earnings estimates for Q1 2025? Immunocore (NASDAQ:IMCR) reported earnings of $0.10 per share for Q1 2025, beating the consensus estimate of -$0.35. The report was announced on Wednesday, May 7, 2025. What was Immunocore's revenue for Q1 2025? Immunocore reported revenue of $125.13 million for Q1 2025, against a consensus estimate of $108.82 million. Immunocore Earnings HeadlinesImmunocore Holdings PLC Sponsored ADR (IMCR) - What Are Analysts Saying About This Stock?November 16 at 2:45 AM | americanbankingnews.comImmunocore FY2026 Earnings Forecast Reduced by HC WainwrightNovember 14 at 2:10 AM | americanbankingnews.comDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall. The free download walks through strategies for navigating the options market, but the window to claim it is closing soon.November 17 at 1:00 AM | TradeWins (Ad)HC Wainwright Has Lowered Expectations for Immunocore (NASDAQ:IMCR) Stock PriceNovember 12, 2026 | americanbankingnews.comImmunocore (NASDAQ:IMCR) Shares Cross Above 200 Day Moving Average After Earnings MissNovember 11, 2026 | americanbankingnews.comImmunocore Holdings plc (IMCR) Presents at Society for Immunotherapy of Cancer's (SITC) 2026 Annual Meeting - SlideshowNovember 10, 2026 | seekingalpha.comSee More Immunocore Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Immunocore? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Immunocore and other key companies, straight to your email. Email Address About ImmunocoreImmunocore (NASDAQ:IMCR) is a biotechnology company that develops T cell receptor (TCR)-based medicines for cancer and other diseases. Its ImmTAX platform is designed to create therapies that direct the body’s T cells toward targets inside cells, including targets that may be difficult for conventional antibody treatments to reach. The company’s marketed medicine, KIMMTRAK (tebentafusp-tebn), is a TCR-based therapy approved in the United States and other markets for certain patients with unresectable or metastatic uveal melanoma. Immunocore is also developing a pipeline of TCR therapies for additional cancers and research programs in infectious and autoimmune diseases. Founded in 2008 and headquartered in the United Kingdom, Immunocore serves patients and pursues commercial and development activities in multiple markets, including the United States and Europe. Bahija Jallal is the company’s chief executive officer.View Immunocore ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its YearThe Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to WatchTyson Foods' Earnings Beat Hides a Warning for Consumer Staples Dividend InvestorsMongoDB's Biggest Advantage May Be GitLab's Biggest WeaknessMicrosoft's Outage Barely Moved Its Stock, But a Bigger Risk May Be BuildingTyson Foods' 10% Surge Puts a Breakout in Sight, But Wall Street Remains CautiousOndas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog? Upcoming Earnings Lowe's Companies (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026)Ross Stores (11/19/2026)Walmart (11/19/2026)Intuit (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.